Activities of Linezolid against nontuberculous mycobacteria

dc.contributor.authorCavusoglu, Cengiz
dc.contributor.authorSoyler, Ilknur
dc.contributor.authorAkinci, Pinar
dc.date.accessioned2019-10-27T20:01:43Z
dc.date.available2019-10-27T20:01:43Z
dc.date.issued2007
dc.departmentEge Üniversitesien_US
dc.description.abstractThe activity of linezolid (Pfizer, USA) was tested by broth microdilution against 53 clinical isolates of non-tuberculous mycobacteria (NTM), including the common disease producing species Mycobacterium avium, M.intracellulare, M.fortuitum, M.chelonae and M.abscessus, obtained from western Turkey The isolates of M.abscessus and M.intracellulare were the least susceptible, M.mucogenicum, M.gordonae and M.avium were the most susceptible to linezolid of the common species of NTM. Linezolid showed a variable sensitivity in all strains; therefore, each species and strain must be individually evaluated, and it is always advisable to perform in vitro sensitivity tests before using the drug for human therapy.en_US
dc.identifier.endpage414en_US
dc.identifier.issn1121-7138
dc.identifier.issue4en_US
dc.identifier.pmid18080676en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage411en_US
dc.identifier.urihttps://hdl.handle.net/11454/41282
dc.identifier.volume30en_US
dc.identifier.wosWOS:000251225500006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherEdizioni Int Srlen_US
dc.relation.ispartofNew Microbiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLinezoliden_US
dc.subjectnontuberculous mycobacteriaen_US
dc.subjectbroth microdilutionen_US
dc.titleActivities of Linezolid against nontuberculous mycobacteriaen_US
dc.typeArticleen_US

Dosyalar